Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock
The author name that previously read.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
American journal of cardiovascular drugs - 19(2019), 2 vom: 01. März, Seite 227-227 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Senatore, Fortunato [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| doi: |
10.1007/s40256-019-00335-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR032953607 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR032953607 | ||
| 003 | DE-627 | ||
| 005 | 20230519104713.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40256-019-00335-7 |2 doi | |
| 035 | |a (DE-627)SPR032953607 | ||
| 035 | |a (SPR)s40256-019-00335-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Senatore, Fortunato |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The author name that previously read | ||
| 700 | 1 | |a Jagadeesh, Gowraganahalli |e verfasserin |4 aut | |
| 700 | 1 | |a Rose, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Pillai, Venkateswaran C. |e verfasserin |4 aut | |
| 700 | 1 | |a Hariharan, Sudharshan |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Ququan |e verfasserin |4 aut | |
| 700 | 1 | |a McDowell, Tzu-Yun |e verfasserin |4 aut | |
| 700 | 1 | |a Sapru, Mohan K. |e verfasserin |4 aut | |
| 700 | 1 | |a Southworth, Mary Ross |e verfasserin |4 aut | |
| 700 | 1 | |a Stockbridge, Norman |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of cardiovascular drugs |d Cham : Springer, 2001 |g 19(2019), 2 vom: 01. März, Seite 227-227 |w (DE-627)SPR032943881 |w (DE-600)2043647-6 |x 1179-187X |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2019 |g number:2 |g day:01 |g month:03 |g pages:227-227 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s40256-019-00335-7 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2019 |e 2 |b 01 |c 03 |h 227-227 | ||